| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.053 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |